HIGH-VOLUME · HOSP-HEAVY
metoclopramide Side Effects
metoclopramide (also sold as Reglan) is HIGH-VOLUME in this FAERS book #136 of 524 by FAERS report count. Signature opener: HOSP-HEAVY - 46.4% mention hospitalization (24,739 reports).
Data updated 2026-05-15
- 53,266
- FAERS reports
FAERS voluntary reports, 1995 to 2025. High volume tracks exposure and reporting culture; see methodology for de-dup rules.
metoclopramide: 46.4% mention hospitalization (24,739 reports). Death stamp DEATH-HEAVY; volume band HIGH-VOLUME #136 of 524 by FAERS report count.
High-report extract for metoclopramide (Reglan): 53,266 FAERS rows (1995-2025). Top named reactions: TARDIVE DYSKINESIA, EXTRAPYRAMIDAL DISORDER, NERVOUS SYSTEM DISORDER. Outcome stamps DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED. FAERS is voluntary signal detection, not incidence.
Counts from the openFDA FAERS extract (1995–2025). Stamps CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
TARDIVE DYSKINESIA leads 13,205 of 53,266 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (11,124 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (7,091 reports, 13.3%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 1,232 |
| PNEUMONIA | 547 |
| TARDIVE DYSKINESIA | 521 |
| VOMITING | 514 |
| NAUSEA | 512 |
| DIARRHOEA | 443 |
| NERVOUS SYSTEM DISORDER | 407 |
| DYSPNOEA | 406 |
| SEPSIS | 338 |
| TOXICITY TO VARIOUS AGENTS | 327 |
| MALIGNANT NEOPLASM PROGRESSION | 309 |
| EXTRAPYRAMIDAL DISORDER | 308 |
| DISEASE PROGRESSION | 306 |
| ACUTE KIDNEY INJURY | 303 |
| PYREXIA | 292 |
| ANAEMIA | 286 |
| CARDIAC ARREST | 282 |
| FATIGUE | 280 |
| RENAL FAILURE | 271 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (24,739, 46.4% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| TARDIVE DYSKINESIA | 2,773 |
| EXTRAPYRAMIDAL DISORDER | 2,756 |
| NERVOUS SYSTEM DISORDER | 2,542 |
| NAUSEA | 2,501 |
| VOMITING | 2,203 |
| DYSTONIA | 1,979 |
| DIARRHOEA | 1,868 |
| FEBRILE NEUTROPENIA | 1,745 |
| PYREXIA | 1,738 |
| DYSPNOEA | 1,421 |
| PNEUMONIA | 1,263 |
| PAIN | 1,176 |
| FATIGUE | 1,164 |
| ABDOMINAL PAIN | 1,106 |
| ANAEMIA | 996 |
| CONSTIPATION | 965 |
| ACUTE KIDNEY INJURY | 918 |
| DEHYDRATION | 917 |
| ASTHENIA | 883 |
How to read metoclopramide FAERS figures (CASELOAD · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 53,266 voluntary reports linked to metoclopramide (Reglan), 1995-2025. Death is listed on 7,091 (13.3%). Hospitalization appears on 24,739 (46.4%). Top co-reported indication: Product Used For Unknown Indication.
CASELOAD books overweight common drugs and loud reporting cultures; HOSP-HEAVY is the page opener, not a per-patient risk.
Read with metoclopramide
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 52,302 FAERS cases (Δ 964 lighter vs metoclopramide); DEATH-MARKED · HOSP-MID · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 54,355 FAERS cases (Δ 1,089 heavier vs metoclopramide); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 51,859 FAERS cases (Δ 1,407 lighter vs metoclopramide); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 51,370 FAERS cases (Δ 1,896 lighter vs metoclopramide); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 48.8 pp vs metoclopramide's DEATH-HEAVY): CASELOAD · HOSP-MID.
metoclopramide stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload CASELOAD and the label guide.